ACAD
31.43
-2.07
-6.18%
AEMD
6.01
-0.13
-2.12%
APRI
0.4
-0.07
-14.89%
ARNA
1.81
-0.1
-5.24%
ATEC
0.28
0.00
-0.99%
CNAT
2.04
-0.09
-4.23%
CRXM
0.17
+0.02
+11.96%
CYTX
2.02
+0.02
+1.00%
DXCM
77.46
-0.13
-0.17%
GNMK
8.35
-0.62
-6.91%
HALO
8.44
-0.75
-8.16%
ILMN
138.91
-7.68
-5.24%
INNV
0.23
+0.01
+2.61%
INO
9.17
-0.68
-6.90%
ISCO
2.05
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
111.79
-3.32
-2.88%
LPTN
2.18
-0.18
-7.63%
MBVX
0.553
-0.028
-4.7414%
MEIP
1.36
+0.02
+1.49%
MNOV
7
-0.11
-1.55%
MRTX
5.98
-0.48
-7.43%
MSTX
0.45
-0.007
-1.4683%
NBIX
43.28
-1.31
-2.94%
NUVA
57.93
-0.93
-1.58%
ONCS
1.63
+0.03
+1.87%
ONVO
3.35
-0.1
-2.90%
OREX
0.449
-0.049
-9.8614%
OTIC
15.58
-0.67
-4.12%
QDEL
17.09
-0.77
-4.31%
RCPT
231.96
0.00
0.00%
RGLS
5.29
-0.45
-7.84%
RMD
60.52
-3.56
-5.56%
SCIE
0.005
0.00
-5.5556%
SPHS
1.86
-0.03
-1.59%
SRNE
5.62
-0.26
-4.42%
TROV
4.55
-0.25
-5.21%
VICL
4.47
-0.13
-2.83%
VOLC
18
0.00
0.00%
ZGNX
8.09
-0.32
-3.80%
ACAD
31.43
-2.07
-6.18%
AEMD
6.01
-0.13
-2.12%
APRI
0.4
-0.07
-14.89%
ARNA
1.81
-0.1
-5.24%
ATEC
0.28
0.00
-0.99%
CNAT
2.04
-0.09
-4.23%
CRXM
0.17
+0.02
+11.96%
CYTX
2.02
+0.02
+1.00%
DXCM
77.46
-0.13
-0.17%
GNMK
8.35
-0.62
-6.91%
HALO
8.44
-0.75
-8.16%
ILMN
138.91
-7.68
-5.24%
INNV
0.23
+0.01
+2.61%
INO
9.17
-0.68
-6.90%
ISCO
2.05
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
111.79
-3.32
-2.88%
LPTN
2.18
-0.18
-7.63%
MBVX
0.553
-0.028
-4.7414%
MEIP
1.36
+0.02
+1.49%
MNOV
7
-0.11
-1.55%
MRTX
5.98
-0.48
-7.43%
MSTX
0.45
-0.007
-1.4683%
NBIX
43.28
-1.31
-2.94%
NUVA
57.93
-0.93
-1.58%
ONCS
1.63
+0.03
+1.87%
ONVO
3.35
-0.1
-2.90%
OREX
0.449
-0.049
-9.8614%
OTIC
15.58
-0.67
-4.12%
QDEL
17.09
-0.77
-4.31%
RCPT
231.96
0.00
0.00%
RGLS
5.29
-0.45
-7.84%
RMD
60.52
-3.56
-5.56%
SCIE
0.005
0.00
-5.5556%
SPHS
1.86
-0.03
-1.59%
SRNE
5.62
-0.26
-4.42%
TROV
4.55
-0.25
-5.21%
VICL
4.47
-0.13
-2.83%
VOLC
18
0.00
0.00%
ZGNX
8.09
-0.32
-3.80%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.